Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S N Batskikh

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Terapevticheskii Arkhiv|February 1, 2019
Hepatic decompensation associated with an interferon-free antiviral therapy in patients with HCV-cirrhosisS N Batskikh, E V Vinnitskaya, Yu G Sandler, et al.
Terapevticheskii Arkhiv|June 30, 2020
[Hepatic decompensation associated with an interferon-free antiviral therapy in patients with HCV-cirrhosis]S N Batskikh, E V Vinnitskaya, Y G Sandler, et al.
Terapevticheskii Arkhiv|April 1, 2016
[Resistance to protease inhibitors and efficiency of antiviral therapy in patients with chronic hepatitis C]S N Batskikh, I V Karandashova, A D Neverov, et al.
Terapevticheskii Arkhiv|December 21, 2012
[Hepatitis C virus genotype 3: that simple, yet that complex (corrected)]S N Batskikh, S V Morozov, V P Chulanov, et al.
Terapevticheskii Arkhiv|May 11, 2023
[Assessment of the possible impact of hepatitis viruses on the development and course of autoimmune liver diseases]E S Sbikina, E V Vinnitskaya, S N Batskikh, et al.
Terapevticheskii Arkhiv|June 30, 2020
[Efficacy and safety of narlaprevir/ritonavir and daclatasvir non interferon combination in population of Russian patients with chronic hepatitis C]E A Klimova, E Z Burnevich, V P Chulanov, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Terapevticheskii Arkhiv|February 1, 2019
Hepatic decompensation associated with an interferon-free antiviral therapy in patients with HCV-cirrhosisS N Batskikh, E V Vinnitskaya, Yu G Sandler, et al.
Terapevticheskii Arkhiv|June 30, 2020
[Hepatic decompensation associated with an interferon-free antiviral therapy in patients with HCV-cirrhosis]S N Batskikh, E V Vinnitskaya, Y G Sandler, et al.
Terapevticheskii Arkhiv|April 1, 2016
[Resistance to protease inhibitors and efficiency of antiviral therapy in patients with chronic hepatitis C]S N Batskikh, I V Karandashova, A D Neverov, et al.
Terapevticheskii Arkhiv|December 21, 2012
[Hepatitis C virus genotype 3: that simple, yet that complex (corrected)]S N Batskikh, S V Morozov, V P Chulanov, et al.
Terapevticheskii Arkhiv|May 11, 2023
[Assessment of the possible impact of hepatitis viruses on the development and course of autoimmune liver diseases]E S Sbikina, E V Vinnitskaya, S N Batskikh, et al.
Terapevticheskii Arkhiv|June 30, 2020
[Efficacy and safety of narlaprevir/ritonavir and daclatasvir non interferon combination in population of Russian patients with chronic hepatitis C]E A Klimova, E Z Burnevich, V P Chulanov, et al.
Pageof 1